Bridgewater Chapter Upcoming Events Join PCCI

Member Profiles


Harvey D. Homan, Ph.D, MBA

Executive Director of Corporate Development


Harvey D. Homan has wide-ranging experience developing and growing businesses in the consumer health, pharmaceutical and medical device industries – both in the U.S. and Europe – by driving innovation in product portfolio development and business modeling.  Currently, he serves as Executive Director of Corporate Development for the Institute for Life Science Entrepreneurship (ILSE) where he leads the ILSE Accelerator, ILSE Ventures, redefinition of the business plan,


Harvey D. Homan

and building relationships with life science companies and universities throughout the region. He also serves as a faculty member of NYCRIN for the NSF I-Corps program, as a mentor in the NYU Blackstone Launchpad, and as an EIR at EDC@NJIT, in addition to working with early stage life science companies in various capacities.


Throughout his career, Dr. Homan has leveraged his scientific background and business acumen to successfully develop and commercialize hundreds of products, from invention through R&D, regulatory, clinical and marketing phases. He also has led numerous in-licenses and product partnerships. As CEO of Ingenion Medical Limited, SR Holding 1 Co, Urovalve, Inc. and Linguagen Corp., Dr. Homan has led companies from formations in USA and UK through marketing authorization.


With the U.K.’s The Boots Company, Dr. Homan led all scientific, medical, regulatory and product-related functions for start-up of the new consumer-focused Boots Healthcare International, with teams in the UK, France and Germany. He played a leading role in building a new Division to > £500 million revenue in, including leadership of the integration of R&D and all scientific, medical and regulatory functions for two major acquisitions; product acquisitions and development partnerships with European, U.S., Indian and Japanese companies. During his last year, on assignment from the Boots chairman, he headed Corporate Development and Innovation, where he led analysis of international best practices that revealed needed process and organizational changes and he coached executives and board members in value creation through innovation. Starting with Sterling Drug Inc., he rapidly progressed through clinical science and marketing/sales executive roles to leadership of R&D, regulatory and clinical affairs for Sterling Health Europe, managing the global new product portfolio and developing innovative approaches to product development.


Dr. Homan holds a MBA, Marketing, from New York University, and a Ph.D. in Pharmacology from the University of Georgia.






Contact Info:


HDH Associates International LLC

Tel: 908-432-2150



Good Company! Good Drink! Good Food! Good Program! Good Fun!


Site Navigation



Pharmaceutical Consulting Consortium International, Inc., or (610) 296-8086

Meetings Held at Embassy Suites - Valley Forge

888 Chesterbrook Blvd, Chesterbrook, Pennsylvania 19087

All content on this website is copyrighted and should not be reproduced without the consent of PCCI.

© Copyright 2016-2018



Tat Communication Inc